Fosun

Earlier this year, Fosun also agreed to sell its 4.89% stake in Tsingtao Brewery Co Ltd and is reducing its stake in Fosun Tourism too.

BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China

The vaccine, known as BNT162b2, will be tested on volunteers at the Jiangsu Provincial Center for Disease Control and Prevention to assess safety and immunogenicity, eyeing future approval in China, the two companies said in a statement.

3-Point Analysis | Backed by a Chinese firm, Gland Pharma, gets IPO nod from SEBI

If the listing plans fructify, it would also mark the first major IPO by an Indian company that has a Chinese parent.

Gland Pharma gets Sebi approval for Rs 6,000-crore IPO, set for first listing of an Indian firm with a Chinese parent

The IPO is a mixture of primary and secondary issue of shares with both China’s Fosun group and the founders of Gland Pharma due to dilute shares. Gland Pharma may look to launch the IPO in November 2020

China's Fosun pulls back from healthcare deals worth $300 million in India: Report

As per reports, Fosun had made a formal proposal to purchase stake in two companies.

Exclusive | KKR leads race to buy stake in Piramal's pharma business

The stake-sale process is aimed at raising growth capital and strengthening the Piramal group’s balance sheet.

China's Fosun Pharma cuts size of stake it will buy in Gland Pharma to 74%

Fosun Pharma said Gland Pharma's founding family wanted to retain a higher stake in the Indian firm because of its good performance.

India raises concerns around Chinese firm Fosun's takeover of Gland: Source

The deal has won the approval of the Competition Commission of India (CCI) and India's Foreign Investment Promotion Board (FIPB) in the last few months, but some in the government have expressed concerns, the source said, declining to be named.

China's Fosun to 'acquire' Brazil investment firm

China's Fosun today signed an agreement to acquire Brazil-based investment management firm Rio Bravo, according to a statement, just a day after the Chinese conglomerate announced another massive overseas deal.